thalidomide has been researched along with norethindrone in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (33.33) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Gavan, JA; Wilson, JG | 1 |
| Fradkin, R; Wilson, JG | 1 |
| Abernethy, DR; Collins, JM; Donahue, SR; Flockhart, DA; Thacker, D; Trapnell, CB | 1 |
| Colburn, W; Kook, KA; Scheffler, MR; Thomas, SD | 1 |
2 trial(s) available for thalidomide and norethindrone
| Article | Year |
|---|---|
Thalidomide does not alter the pharmacokinetics of ethinyl estradiol and norethindrone.
Topics: Adult; Area Under Curve; Contraceptives, Oral, Synthetic; Cross-Over Studies; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Immunosuppressive Agents; Middle Aged; Norethindrone; Progesterone Congeners; Thalidomide | 1998 |
Thalidomide does not alter estrogen-progesterone hormone single dose pharmacokinetics.
Topics: Administration, Oral; Adult; Antineoplastic Agents, Hormonal; Area Under Curve; Contraceptives, Oral, Synthetic; Cross-Over Studies; Dermatologic Agents; Drug Administration Schedule; Ethinyl Estradiol; Female; Half-Life; Humans; Hypnotics and Sedatives; Leprostatic Agents; Norethindrone; Reference Values; Thalidomide | 1999 |
4 other study(ies) available for thalidomide and norethindrone
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Congenital malformations in nonhuman primates: spontaneous and experimentally induced.
Topics: Abnormalities, Drug-Induced; Aminopterin; Animals; Aspirin; Congenital Abnormalities; Female; Haplorhini; Hominidae; Meclizine; Norethindrone; Piperazines; Pregnancy; Pregnancy, Animal; Progesterone; Rubella virus; Testosterone; Thalidomide | 1967 |
Teratogeny in nonhuman primates, with notes on breeding procedures in Macaca mulatta.
Topics: Abnormalities, Drug-Induced; Androgens; Animals; Breeding; Chorionic Gonadotropin; Congenital Abnormalities; Female; Haplorhini; Male; Norethindrone; Pregnancy Tests; Rubella virus; Species Specificity; Steroids; Thalidomide; Vincristine | 1969 |